Antti Laukkanen

This inventor holds 27 USPTO granted patents and 7 published patent applications, plus 13 CIPO patents and 26 EPO patents, primarily in Nanofibrillar Cellulose. Top assignees: Upm-Kymmene Corporation, Betulium Oy, Kemira Oyj. Active years: 2014-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antti Laukkanen. Retrieved from https://idiyas.com/inventor/antti-laukkanen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 7)

% Patents Active = 88.9

CIPO Patents = 13 (Patent Applications = 1)

EPO Patents = 26 (Patent Applications = 36)

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 68(Granted Patents)

Company Filing History:

22 out of 216

Upm-Kymmene Corporation

where one patent can have more than one assignee

Years Active: 2014-2022

Loading Chart...

Areas of Expertise:

Drug Delivery

Fibril Cellulose

Nanofibrillar Cellulose

Microbial Culture

Cellulose Composition

Paper Production

Cell Culture Material

Cementitious Additive

Phase Separation Agent

Soil Treatment

Composite Manufacturing

Oxidized Cellulose

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11389537 - Drug delivery system for sustained delivery of bioactive agents (2022-07-19),

2. 11299852 - Method for producing parenchymal cell cellulose (2022-04-12),

3. 11286313 - Parenchymal cellulose composition (2022-03-29),

4. 11207803 - Method for preparing a membrane from fibril cellulose and fibril, cellulose membrane (2021-12-28),

5. 11131062 - Method for producing paper, board or the like (2021-09-28),

6. 10767312 - Method for producing paper, board or the like (2020-09-08),

7. 10640632 - Bimodal cellulose composition (2020-05-05),

8. 10625232 - Treating nanofibrillar cellulose hydrogel at elevated temperature (2020-04-21),

9. 10612003 - Plant derived cell culture material (2020-04-07),

10. 10538735 - Matrix and composition for microbial culture of gram-positive bacteria (2020-01-21),

11. 10538734 - Composition for embedded microbial culture (2020-01-21),

12. 10527582 - Use of stationary phase comprising fibril cellulose in separation methods (2020-01-07),

13. 10520485 - Analytical method for determining the concentration of oxidized nanofibrillar cellulose in a sample (2019-12-31),

14. 9975062 - Nanofibrillar cellulose as a phase separation agent (2018-05-22),

15. 9963625 - Composite body and method of manufacturing it (2018-05-08),

Title: Antti Laukkanen: Innovator in Drug Delivery Systems

Introduction

Antti Laukkanen, a prominent inventor based in Helsinki, Finland, has significantly contributed to the field of biotechnology and materials science. With an impressive portfolio of 27 patents, he has made strides in developing innovative solutions for drug delivery and cellulose production.

Latest Patents

Among his latest innovations, Laukkanen has developed a groundbreaking drug delivery system designed for the sustained delivery of bioactive agents. This system features a matrix made from nanofibrillated cellulose derived from plant-based materials, along with at least one bioactive agent and a variety of supports including synthetic polymers, bio compounds, and natural polymers. In addition, he has created methods for manufacturing this drug delivery system and techniques for utilizing it effectively.

Another notable patent involves a method for producing parenchymal cell cellulose. This innovative process employs a high consistency alkali treatment and may include an optional refinement step, as well as an apparatus designed for its manufacturing.

Career Highlights

Antti Laukkanen has had a successful career, notably working with respected companies such as UPM-Kymmene Corporation and Betulium Oy. His experience in these organizations has provided him with the platform to develop his revolutionary ideas and bring them to fruition.

Collaborations

Throughout his career, Laukkanen has collaborated with talented individuals in the field, including Jan-Erik Teirfolk and Markus Nuopponen. These partnerships have enabled him to leverage combined expertise, pushing the boundaries of innovation in his ventures.

Conclusion

Antti Laukkanen continues to be a vital figure in the innovation landscape, particularly in drug delivery systems and cellulose production. His commitment to advancing technology through his numerous patents showcases his dedication and talent as an inventor. With ongoing developments, he is poised to make an even greater impact in the future.

Profile summary based on public USPTO records.